RALYPHARM
The KBO register records legal situation 013 for RALYPHARM (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. The 2019 annual accounts show equity of €407k and a net result of €301k.
| Equity | €407k |
| Net result | €301k |
| Active | 16 yrs |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Dissolution or liquidation
The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Show 4 other metrics
| Fiscal year | 2019 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | - |
| Net profit | €301k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | €2k |
| Dividends | - |
| Total assets | €660k |
| Equity | €407k |
| Debt | €253k |
| of which ≤ 1y | €253k |
| of which > 1y | - |
| Working capital | €-250k |
| Employees (FTE) | - |
| 2019 | |
|---|---|
| Current ratio | 0.01 |
| Quick ratio | 0.01 |
| Working capital ratio | -37.9% |
| Solvency | 61.6% |
| Debt / equity | - |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 45.7% |
| ROE | 74.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (20 line items)
| Line item | Code | 2019 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €660k |
| Fixed assets | 21/28 | €657k |
| Financial fixed assets | 28 | €657k |
| Current assets | 29/58 | €3k |
| Cash & bank | 54/58 | €3k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €660k |
| Equity | 10/15 | €407k |
| Contributions / capital | 10/11 | €96k |
| Reserves | 13 | €311k |
| Accumulated profits (losses) | 14 | €310k |
| Amounts payable | 17/49 | €253k |
| Amounts payable within one year | 42/48 | €253k |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €8k |
| Operating result | 9901 | €8k |
| Financial charges | 65 | €62 |
| Result before taxes | 9903 | €8k |
| Income taxes | 67/77 | €2k |
| Net result for the period | 9904 | €6k |
| Result to be appropriated | 9905 | €6k |
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Partnership limited by shares(013) |
| Incorporation | 28-08-2009 |
| Status | Active |
| Postal code | 4570 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 61039B0111/00G000 | Wallonia | 806 m² | 1 · 146 m² | 7.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | RALYPHARM |